The Vacc-iNTS project for the manufacture and clinical development of a vaccine against invasive non-typhoidal salmonellosis (iNTS) disease funded by the European Commission has started. Invasive non-typhoidal salmonellosis is an emerging neglected infectious disease of sub-Saharan Africa that mainly affects children under 5 years of age and immunocompromised subjects. In 2017, iNTS was estimated to … Continue reading MMGH partners in the Vacc-iNTS research project to advance the clinical development of an innovative vaccine against invasive non-typhoidal salmonellosis
We at MMGH work very often on models - business models, investment models, forecasting models. So we found it interesting to reflect about the old that models have in innovation and more extensively in the progress of mankind. This blog post from Bill Gates provide a very interesting perspective on the matter.
Stefano Malvolti, one of our co-founders, is since more than 2 years a member of the Impact Hub, a network of innovators, dreamers and entrepreneurs who are creating tangible solutions to the world’s most pressing issues. In this interview he shares his views about MMGH Consulting, the way we work and how do we want … Continue reading One of our co-founder discusses with Impact Hub about working in global health
The initiative Market Information for Access to Vaccine has been launched by the World Health Organisation (WHO) with the goal of facilitating sustainable and affordable access to supply of vaccines. The new project, a partnership between the WHO, MMGH Consulting and Linksbridge with financial support from the Bill & Melinda Gates Foundation, aims at: (a) enhancing … Continue reading MMGH partners with WHO and Linksbridge to work towards achievement of SDG3
Dear friends and colleagues, During these first days of 2018 we are reflecting on the year that just finished with gratitude and enthusiasm. Professionally, 2017 was a very special year for us. Thanks to the trust of many of you, the creation and launch of MMGH (Malvolti Mantel Global Health) Consulting developed into a noticeable … Continue reading Happy New Year from MMGH Consulting
The role of the World Health Organisation is more important than ever. In a world that is more and more interconnected the threat of pandemics is growing. In parallel the risk of antimicrobial resistance is also increasing. This just two mention two of the key matters the new DG will have to deal with! A … Continue reading A new Director General for the WHO
Interesting interview with Mary Paul Kieny on the opportunity and constraints of using the experimental Ebola vaccine in DRC. One thing is clear: preparation is 90% of the story whatever position expert may have on the matter. Questions on using the experimental Ebola Vaccine